These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 26721723)

  • 1. Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
    Zarrin A; Sadighian S; Rostamizadeh K; Firuzi O; Hamidi M; Mohammadi-Samani S; Miri R
    Int J Pharm; 2016 Mar; 500(1-2):62-76. PubMed ID: 26721723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
    Nejadshafiee V; Naeimi H; Goliaei B; Bigdeli B; Sadighi A; Dehghani S; Lotfabadi A; Hosseini M; Nezamtaheri MS; Amanlou M; Sharifzadeh M; Khoobi M
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():805-815. PubMed ID: 30889755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
    Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
    Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of superparamagnetic iron oxide/doxorubicin loaded chitosan nanoparticles as a promising glioblastoma theranostic tool.
    Gholami L; Tafaghodi M; Abbasi B; Daroudi M; Kazemi Oskuee R
    J Cell Physiol; 2019 Feb; 234(2):1547-1559. PubMed ID: 30145790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic core-shell hybrid nanoparticles for receptor targeted anti-cancer therapy and magnetic resonance imaging.
    Shanavas A; Sasidharan S; Bahadur D; Srivastava R
    J Colloid Interface Sci; 2017 Jan; 486():112-120. PubMed ID: 27697648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theranostic, pH-Responsive, Doxorubicin-Loaded Nanoparticles Inducing Active Targeting and Apoptosis for Advanced Gastric Cancer.
    Ma H; Liu Y; Shi M; Shao X; Zhong W; Liao W; Xing MM
    Biomacromolecules; 2015 Dec; 16(12):4022-31. PubMed ID: 26477267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging.
    Chiang WH; Huang WC; Chang CW; Shen MY; Shih ZF; Huang YF; Lin SC; Chiu HC
    J Control Release; 2013 Jun; 168(3):280-8. PubMed ID: 23562635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting.
    Lee KD; Choi SH; Kim DH; Lee HY; Choi KC
    Arch Pharm Res; 2014 Dec; 37(12):1546-53. PubMed ID: 25280540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
    Rajkumar S; Prabaharan M
    Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging.
    Zhu L; Wang D; Wei X; Zhu X; Li J; Tu C; Su Y; Wu J; Zhu B; Yan D
    J Control Release; 2013 Aug; 169(3):228-38. PubMed ID: 23485450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
    Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
    Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
    Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
    Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active targeted delivery of theranostic thermo/pH dual-responsive magnetic Janus nanoparticles functionalized with folic acid/fluorescein ligands for enhanced DOX combination therapy of rat glioblastoma.
    Ali BH; Khoee S; Mafakheri F; Sadri E; Mahabadi VP; Karimi MR; Shirvalilou S; Khoei S
    J Mater Chem B; 2024 Jun; 12(24):5957-5973. PubMed ID: 38808630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A superparamagnetic polymersome with extremely high T
    Liu Q; Song L; Chen S; Gao J; Zhao P; Du J
    Biomaterials; 2017 Jan; 114():23-33. PubMed ID: 27837682
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Mortezazadeh T; Gholibegloo E; Khoobi M; Alam NR; Haghgoo S; Mesbahi A
    J Drug Target; 2020 Jun; 28(5):533-546. PubMed ID: 31842616
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
    Arabi L; Badiee A; Mosaffa F; Jaafari MR
    J Control Release; 2015 Dec; 220(Pt A):275-286. PubMed ID: 26518722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.